Antibody response to SARS-CoV-2 vaccination is extremely vivacious in subjects with previous SARS-CoV-2 infection

Annapaola Callegaro, Daniela Borleri, Claudio Farina, Gavino Napolitano, Daniela Valenti, Marco Rizzi, Franco Maggiolo
doi: https://doi.org/10.1101/2021.03.09.21253203

Article usage

Article usage: March 2021 to August 2025

AbstractFullPdf
Mar 2021220664358
Apr 202150733182
May 20212032142
Jun 2021107984
Jul 202180657
Aug 2021130861
Sep 2021113160
Oct 202169234
Nov 202186329
Dec 20214109
Jan 202242516
Feb 202234011
Mar 20222815
Apr 20222918
May 202231215
Jun 202223263
Jul 202229256
Aug 20221917
Sep 202234012
Oct 20223304
Nov 20221802
Dec 202228311
Jan 202326010
Feb 20232258
Mar 20231101
Apr 202329210
May 20231314
Jun 20231345
Jul 20231014
Aug 20232085
Sep 20231546
Oct 20231200
Nov 20231111
Dec 20231151
Jan 2024806
Feb 20242133
Mar 2024943
Apr 2024625
May 20241712
Jun 20241769
Jul 2024919
Aug 202422710
Sep 20241915
Oct 20241175
Nov 20241729
Dec 202413111
Jan 20251258
Feb 20257114
Mar 202522116
Apr 202512014
May 20251368
Jun 202531106
Jul 202523711
Aug 2025023
Back to top
Posted March 11, 2021.
Download PDF
Data/Code
Email
Antibody response to SARS-CoV-2 vaccination is extremely vivacious in subjects with previous SARS-CoV-2 infection
Annapaola Callegaro, Daniela Borleri, Claudio Farina, Gavino Napolitano, Daniela Valenti, Marco Rizzi, Franco Maggiolo
medRxiv 2021.03.09.21253203; doi: https://doi.org/10.1101/2021.03.09.21253203
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area